Compare Align Technology, Inc. (ALGN) vs Coupang Inc (CPNG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Coupang Inc — how do they compare? Align Technology, Inc. trades at $175.68 (market cap $13.27B), while Coupang Inc trades at $18.92 (market cap $33.26B). The key difference: Coupang Inc is far larger — about 2.5× Align Technology, Inc.'s market cap, and Align Technology, Inc. is trading nearer its 52-week high, Coupang Inc nearer its low. Which is the better fit depends on your goals.
| ALGN | CPNG | |
|---|---|---|
Market Cap | $13.27B | $33.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $207.19 | $33.53 |
52-Week Low | $124.88 | $15.12 |
Enterprise Value | $12.32B | $32.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
Coupang (CPNG) trades at $18.53, showing minimal daily movement (-0.16%) amid mixed technical signals. The stock maintains bullish moving averages but faces resistance near $20. Fundamentally, revenue growth remains strong at $34.53B (2025) though profitability is inconsistent with recent quarterly EPS misses. Regulatory challenges emerged with a $409 million data breach fine in June 2026, though investor sentiment improved as the penalty was below worst-case fears.
Wall Street maintains strong bullish consensus (87.5% buy ratings) with a $25.80 price target implying 39% upside. Key opportunities include sustained e-commerce growth and operational cash flow strength ($1.77B in 2025), while risks center on regulatory scrutiny, competitive pressures, and volatile profitability. The stock's high P/E (184.18) requires continued execution to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Coupang Inc
Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →
